1. | Shen F. Monoclonal antibodies to mouse lymphocyte differentiation alloantigens. In: Hämmerling GJ, Hämmerling U, Kearney JF, editors. Monoclonal Antibodies and T-Cell Hybridomas: Perspectives and Technical Advances. Amsterdam: Elsevier/North-Holland Biomedical Press; 1981. p. 25-31. (Immunogen) | 2. | Llodrá J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA. 2004;101:11779-84. (FC, IHC-FS) | 3. | Biot C, Rentsch CA, Gsponer JR, Birkhäuser FD, Jusforgues-Saklani H, Lemaître F, et al. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med. 2012;4:137ra72. (FC, IHC-FS) | 4. | Angeli V, Llodrá J, Rong JX, Satoh K, Ishii S, Shimizu T, et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity. 2004;21:561-74. (FC) | 5. | Lapter S, Livnat I, Faerman A, Zipori D. Structure and implied functions of truncated B-cell receptor mRNAs in early embryo and adult mesenchymal stem cells: Cδ replaces Cμ in μ heavy chain-deficient mice. Stem Cells. 2007;25:761-70. (FC) | 6. | Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, Cohen S, et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood. 2007;109:1422-32. (FC) | 7. | Morad V, Pevsner-Fischer M, Barnees S, Samokovlisky A, Rousso-Noori L, Rosenfeld R, et al. The myelopoietic supportive capacity of mesenchymal stromal cells is uncoupled from multipotency and is influenced by lineage determination and interference with glycosylation. Stem Cells. 2008;26:2275-86. (FC) |
|
Cy® is a registered trademark of GE Healthcare
|